Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07255287 · ClinicalTrials.gov registry record · NA
Behavioral Weight Loss and Sleep Health Intervention
A NA study of Overweight and Obese Adults, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT07255287: Recruiting NA study of Overweight and Obese Adults, sponsored by University of Colorado, Denver.
NCT07255287 is a NA study of Overweight and Obese Adults that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07255287, a NA study of Overweight and Obese Adults, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 6-month single-arm pilot and feasibility study designed to examine if a behavioral weight loss (BWL) intervention with an added sleep health program (BWL+SLEEP) can achieve clinically meaningful weight loss and improvements in a composite sleep health score. The investigators will also evaluate the feasibility of recruitment and retention of study participants and will obtain feedback from participants to improve the program's incorporation of strategies to improve sleep health.
Primary Outcome
Feasibility of enrollment will be assessed by whether the study team can enroll the target sample size of n=20 individuals in the study over a 3-4 month period.
Conditions Studied
Interventions
- BEHAVIORAL BWL+Sleep
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045 - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-12 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT07255287 shows while recruiting
NCT07255287 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Overweight and Obese Adults appearing as the primary indexed condition, and to 1 intervention - of which BWL+Sleep is the first listed.
NCT07255287 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT07255287 about?
NCT07255287 is a clinical study titled "Behavioral Weight Loss and Sleep Health Intervention". This is a 6-month single-arm pilot and feasibility study designed to examine if a behavioral weight loss (BWL) intervention with an added sleep health program (BWL+SLEEP) can achieve clinically meaningful weight loss and improvements in a composite sleep health score. The investigators will also eva...
What is the current status of trial NCT07255287?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-12. Estimated completion is 2027-03.
What conditions does trial NCT07255287 study?
This clinical trial studies the following conditions: Overweight and Obese Adults.
What interventions are being tested in trial NCT07255287?
The interventions under investigation include: BWL+Sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT07255287?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07255287 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07255287's enrollment target sits among peer trials
25 1713th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia